サマリー

報告書の範囲

本レポートでは、動物モデル市場、3D培養市場、オルガノイド市場の3つの世界市場を解説しています。特にオルガノイド市場については、レポートの別章で異なるセグメントの市場推定を行い、より詳細に記述しています。

レポートには以下の内容が含まれます。

- 26のデータテーブルと28の追加テーブル
- 実験動物モデル、3D細胞培養、オルガノイドの世界市場に関する最新レビューと業界内の分析
- 2019年から2021年の歴史的な市場収益データ、2022年の推定値、2027年までの年間複合成長率（CAGR）の予測による世界市場動向の分析
- 産業構造の現状、新規技術のアップデート、オルガノイドの統合と厳しい規制制約を取り巻く問題、進行中の研究活動、市場全体に対するCOVID-19の影響についてのハイライト
- オルガノイドの実際の市場規模の推定と市場予測（百万ドル単位）、および製品タイプ、用途、地域別に対応する市場シェア分析
- アメリカ、カナダ、ドイツ、イギリス、フランス、イタリア、スペイン、日本、オーストラリア、中国、インドなどにおけるオルガノイドの地域別・国別データおよび分析
- 毒性試験や化学物質の安全性・代謝評価に動物が使用される基礎研究、生物医学、その他の産業に大きく影響する現在のトレンドに関する情報
- バイオ医薬品産業における3D細胞培養、動物モデル、オルガノイドのメリットとデメリットを総合的に検討した市場機会の分析
- オルガノイドに関する特許と特許出願のレビュー、および世界市場における新たな展開のレビュー
- 主要な利害関係者の特定と、最近の開発およびセグメント別の収益に基づく競争状況の分析
- Cellesce Ltd.、Corning Inc.、Merck KGaA、Thermo Fisher Scientific Inc.、Hubrecht Organoid Technology（HUB）、STEMCELL Technologies Incなど、オルガノイド市場の主要企業の詳細な企業プロフィール。

ページTOPに戻る

目次

Table of Contents
Chapter 1 Introduction
Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Information Sources and Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Animal Model Market Technology Background
Methods of Animal Model and 3D Cell Culture Modification
Physical and Chemical Mutations
Targeted Mutations
Other Technologies
Laboratory Animal Models
Market Definition
Animal Model Lines
Common Species of Laboratory Animals
Chapter 4 Impact of COVID-19 on the Global Market for Organoids
Overview
Impact of COVID-19 on Organoids
Conclusion
Chapter 5 Market Dynamics
Market Drivers
Increasing Emphasis on Developing Alternative Approaches to Animal Testing
Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth
Increasing Adoption of the Organoid Technology for Wide Range of Applications
Market Restraints
Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells
Concerns Associated with the Integration of Organoids into Current Workflows
Market Opportunities
Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine
Chapter 6 3D Cell Technology Background
3D Cell Cultures
Spheroids
2D Cultures vs. 2.5D Cultures vs. 3D Cultures
Scaffold-Based and Scaffold-Free 3D Cell Cultures
Scaffold-Free 3D Cell Cultures
Scaffold-Based 3D Cell Cultures
Tissue Engineering and Bioprinting
3D Bioprinting Technology
Types of Bioprinting Methods
Microfluidic Organ-on-Chip Platforms
Types of Organ-on-Chip Devices
Chapter 7 Market Breakdown by Organ Type
Global Market for Organoids, by Organ Type
Intestine
Market Size and Forecast
Liver
Market Size and Forecast
Stomach
Market Size and Forecast
Pancreas
Market Size and Forecast
Lung (Pulmonary)
Market Size and Forecast
Kidney
Market Size and Forecast
Others
Cardiac Organoids
Cancer Organoids
Market Size and Forecast
Chapter 8 Market Breakdown by Application
Global Market for Organoids, by Application
Developmental Biology
Market Size and Forecast
Drug Discovery and Personalized Medicine
Market Size and Forecast
Regenerative Medicine
Market Size and Forecast
Pathology of Infectious Disease
Market Size and Forecast
Drug Toxicity and Efficacy Testing
Market Size and Forecast
Chapter 9 Market Breakdown by Region
Global Market for Organoids, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
Chapter 10 Patent Review/New Developments
Chapter 11 Analysis of Market Opportunities
Market Opportunities: Animal Models
Market Opportunities: 3D Cell Culture Segment
Organs-on-Chip
Organoids
Bioprinting
Advantages and Disadvantages of 3D Cell Cultures and Animal Models
Animal Models
3D Cell Cultures in General
Organoids
Organs-on-Chip
Chapter 12 Competitive Landscape
Chapter 13 Profiles of Companies and Important Institutions
Animal Model Companies
ALPHA GENESIS INC.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
ENVIGO
GENOWAY S.A.
LABCORP DRUG DEVELOPMENT (COVANCE INC.)
THE JACKSON LABORATORY
JANVIER LABS
OAK HILL GENETICS
PRIMGEN
TACONIC BIOSCIENCES
TRANSGENIC INC.
TRANSPOSAGEN BIOPHARMACEUTICALS INC.
Bioprinting and Regenerative Medicine Companies
ALLEVI
ASPECT BIOSYSTEMS LTD.
BIOINK SOLUTIONS INC.
CELLINK INC.
COLLPLANT HOLDINGS LTD.
EAST RIVER BIOSOLUTIONS/XYLYX BIO
EPIBONE
MATTEK CORP.
NANO 3D BIOSCIENCES INC.
ORGANOVO HOLDINGS INC.
PEPGEL LLC
REGENHU
TEVIDO BIODEVICES INC.
TISSUSE GMBH
Organ-on-Chip Companies
AXOSIM
EMULATE INC.
KIRKSTALL LTD.
MICRONIT MICROTECHNOLOGIES
MIMETAS
TARA BIOSYSTEMS INC.
Organoid Companies
3DNAMICS INC.
CELLESCE
CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER
CROWN BIOSCIENCE
CORNING INC.
DEFINIGEN
HUBRECHT ORGANOID TECHNOLOGY (HUB)
MERCK KGAA
R&D SYSTEMS INC.
STEMCELL TECHNOLOGIES INC.
THERMO FISHER SCIENTIFIC
TREVIGEN INC. (BIO-TECHNE)
Other 3D Cell Culture Companies
3D BIOTEK LLC
ADVANCED BIOMATRIX INC.
HORIZON DISCOVERY LTD.
INSPHERO INC.
PROMOCELL GMBH
REPROCELL INC.
SYNTHECON INC.